466 related articles for article (PubMed ID: 28187283)
1. Applications of Immunogenomics to Cancer.
Liu XS; Mardis ER
Cell; 2017 Feb; 168(4):600-612. PubMed ID: 28187283
[TBL] [Abstract][Full Text] [Related]
2. Best practices for bioinformatic characterization of neoantigens for clinical utility.
Richters MM; Xia H; Campbell KM; Gillanders WE; Griffith OL; Griffith M
Genome Med; 2019 Aug; 11(1):56. PubMed ID: 31462330
[TBL] [Abstract][Full Text] [Related]
3. Personalized neoantigen vaccines: A new approach to cancer immunotherapy.
Aldous AR; Dong JZ
Bioorg Med Chem; 2018 Jun; 26(10):2842-2849. PubMed ID: 29111369
[TBL] [Abstract][Full Text] [Related]
4. TSNAdb: A Database for Tumor-specific Neoantigens from Immunogenomics Data Analysis.
Wu J; Zhao W; Zhou B; Su Z; Gu X; Zhou Z; Chen S
Genomics Proteomics Bioinformatics; 2018 Aug; 16(4):276-282. PubMed ID: 30223042
[TBL] [Abstract][Full Text] [Related]
5. Landscape of tumor-infiltrating T cell repertoire of human cancers.
Li B; Li T; Pignon JC; Wang B; Wang J; Shukla SA; Dou R; Chen Q; Hodi FS; Choueiri TK; Wu C; Hacohen N; Signoretti S; Liu JS; Liu XS
Nat Genet; 2016 Jul; 48(7):725-32. PubMed ID: 27240091
[TBL] [Abstract][Full Text] [Related]
6. Genomic analysis of 63,220 tumors reveals insights into tumor uniqueness and targeted cancer immunotherapy strategies.
Hartmaier RJ; Charo J; Fabrizio D; Goldberg ME; Albacker LA; Pao W; Chmielecki J
Genome Med; 2017 Feb; 9(1):16. PubMed ID: 28231819
[TBL] [Abstract][Full Text] [Related]
7. Neoantigen vaccine: an emerging tumor immunotherapy.
Peng M; Mo Y; Wang Y; Wu P; Zhang Y; Xiong F; Guo C; Wu X; Li Y; Li X; Li G; Xiong W; Zeng Z
Mol Cancer; 2019 Aug; 18(1):128. PubMed ID: 31443694
[TBL] [Abstract][Full Text] [Related]
8. The present status and future prospects of peptide-based cancer vaccines.
Hirayama M; Nishimura Y
Int Immunol; 2016 Jul; 28(7):319-28. PubMed ID: 27235694
[TBL] [Abstract][Full Text] [Related]
9. MHC class II restricted neoantigen: A promising target in tumor immunotherapy.
Sun Z; Chen F; Meng F; Wei J; Liu B
Cancer Lett; 2017 Apr; 392():17-25. PubMed ID: 28104443
[TBL] [Abstract][Full Text] [Related]
10. Proteogenomic discovery of cancer antigens: Neoantigens and beyond.
Kanaseki T; Tokita S; Torigoe T
Pathol Int; 2019 Sep; 69(9):511-518. PubMed ID: 31397525
[TBL] [Abstract][Full Text] [Related]
11. Population-level distribution and putative immunogenicity of cancer neoepitopes.
Wood MA; Paralkar M; Paralkar MP; Nguyen A; Struck AJ; Ellrott K; Margolin A; Nellore A; Thompson RF
BMC Cancer; 2018 Apr; 18(1):414. PubMed ID: 29653567
[TBL] [Abstract][Full Text] [Related]
12. Identification of Neoantigen-Reactive Tumor-Infiltrating Lymphocytes in Primary Bladder Cancer.
Leko V; McDuffie LA; Zheng Z; Gartner JJ; Prickett TD; Apolo AB; Agarwal PK; Rosenberg SA; Lu YC
J Immunol; 2019 Jun; 202(12):3458-3467. PubMed ID: 31036766
[TBL] [Abstract][Full Text] [Related]
13. DeepHLApan: A Deep Learning Approach for Neoantigen Prediction Considering Both HLA-Peptide Binding and Immunogenicity.
Wu J; Wang W; Zhang J; Zhou B; Zhao W; Su Z; Gu X; Wu J; Zhou Z; Chen S
Front Immunol; 2019; 10():2559. PubMed ID: 31736974
[TBL] [Abstract][Full Text] [Related]
14. Cancer Neoantigens and Applications for Immunotherapy.
Desrichard A; Snyder A; Chan TA
Clin Cancer Res; 2016 Feb; 22(4):807-12. PubMed ID: 26515495
[TBL] [Abstract][Full Text] [Related]
15. pVACtools: A Computational Toolkit to Identify and Visualize Cancer Neoantigens.
Hundal J; Kiwala S; McMichael J; Miller CA; Xia H; Wollam AT; Liu CJ; Zhao S; Feng YY; Graubert AP; Wollam AZ; Neichin J; Neveau M; Walker J; Gillanders WE; Mardis ER; Griffith OL; Griffith M
Cancer Immunol Res; 2020 Mar; 8(3):409-420. PubMed ID: 31907209
[TBL] [Abstract][Full Text] [Related]
16. [Neoantigens and Whole-Exome Sequencing].
Karasaki T; Nakajima J; Kakimi K
Gan To Kagaku Ryoho; 2016 Jul; 43(7):791-7. PubMed ID: 27431622
[TBL] [Abstract][Full Text] [Related]
17. Tumor-Infiltrating Lymphocyte Therapy and Neoantigens.
Robbins PF
Cancer J; 2017; 23(2):138-143. PubMed ID: 28410302
[TBL] [Abstract][Full Text] [Related]
18. Personalized cancer vaccines: Targeting the cancer mutanome.
Zhang X; Sharma PK; Peter Goedegebuure S; Gillanders WE
Vaccine; 2017 Feb; 35(7):1094-1100. PubMed ID: 27449681
[TBL] [Abstract][Full Text] [Related]
19. Update on Tumor Neoantigens and Their Utility: Why It Is Good to Be Different.
Lee CH; Yelensky R; Jooss K; Chan TA
Trends Immunol; 2018 Jul; 39(7):536-548. PubMed ID: 29751996
[TBL] [Abstract][Full Text] [Related]
20. Neoantigen Discovery in Human Cancers.
Mardis ER
Cancer J; 2017; 23(2):97-101. PubMed ID: 28410296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]